1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Forced LMX1A expression induces dorsal neural fates and disrupts patterning of human embryonic stem cells into ventral midbrain dopaminergic neurons
(
- Contribution to journal › Article
-
Mark
Clinical translation of pluripotent stem cell-based therapies : successes and challenges
(
- Contribution to journal › Article
- 2023
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(
- Contribution to journal › Article
- 2022
-
Mark
Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced Dyskinesia
(
- Contribution to journal › Article
- 2021
-
Mark
Bringing Advanced Therapies for Parkinson's Disease to the Clinic : The Scientist's Perspective
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Report of the international conference on manufacturing and testing of pluripotent stem cells
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease
(
- Contribution to journal › Article